A Cambridge company’s technology which can cut the diagnosis times for rare genetic diseases is being made available on the NHS.
Related News Articles
Partnership harnesses UK health and life sciences expertise
Impact report highlights successes of Research England-funded NHSA and MedCity partnership
Two Digital Health Hubs awarded to the North of England
Two Engineering and Physical Sciences Research Council (EPSRC) Health Hubs have been created in the North
Join us for a Meet and Match Cell and Gene Therapy event with our UK and German partners
Join us for a meet and match cell and gene therapy event with UK and German Partners